$28.70
3.21[12.59%]
At close: Apr 26
$28.70
0[0.00%]
After Hours: 5:13PM EDT
PTC Therapeutics
(NASDAQ:PTCT)PTC Therapeutics Stock (NASDAQ:PTCT), Insider Trading Activity
PTC Therapeutics: Insider buying and selling updated today.
Insider Shares Owned
1.315M
Insider Percentage Owned
1.72%
Institutional Shares Held
44.278M
Institutional Percentage Held
57.8%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2024 | Matthew Klein | CHIEF EXECUTIVE OFFICER | -3.361K | $24.89 | -$83.67K | SELL | -1.47% | 225.807K | Apr 19 | View |
| Apr 19, 2024 | Eric Pauwels | CHIEF EXECUTIVE OFFICER | -787 | $25.14 | -$19.78K | SELL | -1.15% | 67.694K | Apr 17 | View |
| Apr 19, 2024 | Matthew Klein | CHIEF EXECUTIVE OFFICER | -1.307K | $25.13 | -$32.85K | SELL | -0.57% | 229.168K | Apr 17 | View |
| Apr 04, 2024 | Scott Lee Golden | EVP & CHIEF MEDICAL OFFICER | -526 | $28.37 | -$14.92K | SELL | -0.87% | 59.988K | Apr 02 | View |
| Feb 01, 2024 | Gregory Neil Almstead | CHIEF TECHNICAL OPS OFFICER | -646 | $27.25 | -$17.60K | SELL | -14.84% | 3.706K | Jan 30 | View |
| Feb 01, 2024 | Elliott Mark Boulding | EXEC. VP AND CLO | -794 | $27.25 | -$21.64K | SELL | -1.10% | 71.189K | Jan 30 | View |
| Feb 01, 2024 | Eric Pauwels | CHIEF BUSINESS OFFICER | -366 | $27.25 | -$9.97K | SELL | -0.82% | 44.181K | Jan 30 | View |
| Feb 01, 2024 | Marie Christine Utter | SVP, CHIEF ACCOUNTING OFFICER | -318 | $27.25 | -$8.67K | SELL | -0.89% | 35.528K | Jan 30 | View |
| Jan 24, 2024 | Steven Allan Jacobson | 0 | $27.22 | -$3.30K | SELL-OPTIONS | 0.00% | 12.348K | Jan 22 | View | |
| Jan 10, 2024 | Marie Christine Utter | SVP, FINANCE & CAO | -2.841K | $28.86 | -$81.99K | SELL | -7.34% | 35.846K | Jan 08 - Jan 09 | View |
| Jan 10, 2024 | MICHAEL SCHMERTZLER | -1.5K | $27.81 | -$41.72K | SELL | -1.28% | 115.266K | Jan 08 | View | |
| Jan 10, 2024 | Eric Pauwels | CHIEF BUSINESS OFFICER | -3.634K | $28.85 | -$104.85K | SELL | -7.54% | 44.547K | Jan 08 - Jan 09 | View |
| Jan 10, 2024 | Matthew Klein | CHIEF EXECUTIVE OFFICER | -7.68K | $28.91 | -$222.00K | SELL | -4.57% | 160.475K | Jan 08 - Jan 09 | View |
| Jan 10, 2024 | Scott Lee Golden | CHIEF MEDICAL OFFICER | -2K | $28.87 | -$57.74K | SELL | -5.01% | 37.914K | Jan 08 - Jan 09 | View |
| Jan 10, 2024 | Elliott Mark Boulding | EXEC. VP AND CLO | -3.395K | $28.85 | -$97.96K | SELL | -4.50% | 71.983K | Jan 08 - Jan 09 | View |
| Jan 10, 2024 | Gregory Neil Almstead | CHIEF TECHNICAL OPS OFFICER | -2.91K | $28.85 | -$83.95K | SELL | -43.80% | 3.734K | Jan 08 - Jan 09 | View |
| Jan 09, 2024 | Matthew Klein | CHIEF EXECUTIVE OFFICER | -10.107K | $27.15 | -$274.39K | SELL | -5.67% | 168.155K | Jan 05 | View |
| Dec 14, 2023 | Pierre Gravier | CHIEF FINANCIAL OFFICER | 7.7K | $25.81 | $198.74K | BUY | 29.62% | 33.7K | Dec 12 | View |
| Sep 08, 2023 | Alethia Young | 0 | $33.85 | -$140.07K | SELL-OPTIONS | 0.00% | 9.067K | Sep 06 | View | |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.